Universe Pharmaceutical Class AUPC
13F holders, Q4 2025 (December 31)1holders −1
0new positions
1sold out
$3.81avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Universe Pharmaceutical Class A (UPC) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holder was UBS Group AG ($4K).
- Company
- Universe Pharmaceutical Class A
- CUSIP
- G9442G138
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $9K |
All 13F filers, Q3 2025 → Q4 2025: 945 shares bought and 2,000 shares sold, net −1,055 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| UBS Group AG | 0.00% | Add +94500.0% | 946 | $4K |
"% of holder's portfolio" is UPC's weight in each manager's 13F, not the share of Universe Pharmaceutical Class A the manager owns.